Hemp Extracts

‘The risk we have here is enough to manage’: Athlete turned entrepreneur Floyd Landis discusses how regulatory uncertainty threatens the global CBD industry

15-Sep-2023 By Oliver Morrison

Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

CBD in 2022: A year in review

06-Dec-2022 By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

‘A continuing pattern of antagonism by FDA toward CBD in food and beverages’: Experts weigh in on recent warning letters

05-Dec-2022 By Stephen Daniells

The recent raft of warning letters to brands selling CBD-infused foods and beverages marked a shift in FDA approaches to the ingredient, with the Agency seeming to opine that food and beverages are “somehow a greater risk than supplements”.

'Quite frankly, I'm concerned for our entire industry...' FDA cracks down on firms selling CBD-infused foods & beverages in ‘aggressive’ new stance

22-Nov-2022 By Elaine Watson

The FDA has sent out a raft of warning letters to brands selling CBD-infused foods and beverages, adopting an “aggressive position” that one industry source told us made him “concerned for our entire industry.”

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

CBD brand Trip expands its foothold in US, launches gummies with $12m fundraise

26-Aug-2022 By Elizabeth Crawford

After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Provisions of Senate bill could decimate hemp industry, industry group asserts

10-Aug-2022 By Hank Schultz

Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.

Majority of CBD products tested in study found to have at least some THC

29-Jun-2022 By Hank Schultz

A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.

Kemin enters hemp-CBD space with Luxiva distillates range

15-Jun-2022 By Stephen Daniells

Iowa-based Kemin is expanding its portfolio to introduce a range of USDA-certified organic, traceable, U.S.-grown hemp CBD distillates for use in health and wellness products.

FDA slams Delta-8 THC sellers over claims

04-May-2022 By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

Best companies will prevail as CBD market goes through painful winnowing, CEO says

24-Feb-2022 By Hank Schultz

The hemp/CBD market is going through a reckoning but ultimately will emerge in a stronger position, said the head of one of few publicly traded companies in the sector.

USP commentary sounds safety, quality alarm on delta-8 THC

03-Dec-2021 By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

California Gov. Newsom expected to sign hemp bill

13-Sep-2021 By Hank Schultz

The California Legislature has passed a bipartisan bill to establish rules for the production and marketing of CBD/hemp products. Proponents expect Gov. Gavin Newsom to sign the bill into law before the Oct. 10 deadline.

FDA rejects two NDI filings on full spectrum hemp extracts

11-Aug-2021 By Hank Schultz

The US Food and Drug Administration has rejected two New Dietary Ingredient Notifications for CBD ingredients. Industry stakeholders said the fact of the rejections and some of wording used in the letters makes it clear that new legislation is likely...

Schumer bill mandates legal pathway for CBD supplements, directs FDA to set safe upper exposure limit

15-Jul-2021 By Hank Schultz

A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.

‘Full spectrum CBD’ means being honest about the THC content, manufacturer says

06-Jul-2021 By Hank Schultz

Not shying away from the THC content is the best way to offer a ‘full spectrum’ CBD product, a Kentucky-based manufacturer advocates.

Hemp advocates say recent FDA communique makes need for legislation even more pressing

01-Jul-2021 By Hank Schultz

The publication of a recent FDA priorities list that omitted the hemp/CBD question is a reminder that a legislative solution is the only practical way forward for a regulatory resolution for these ingredients, advocates say.

Bipartisan Senate CBD bill introduced

19-May-2021 By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

Introduction of Senate hemp market bill expected soon

17-May-2021 By Hank Schultz

A Senate version of a bill legalizing CBD as a dietary ingredient is reportedly slated to be introduced soon, perhaps as early as this week.

CV Sciences’ revenue plummets, reflecting overall contraction of CBD market

14-May-2021 By Hank Schultz

CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.

CV Sciences, Alkemist Labs team up with NIST to improve hemp/CBD testing

14-Apr-2021 By Hank Schultz

Leading hemp/CBD firm CV Sciences is partnering with Alkemist Labs and a government agency to improve the state of the art in cannabinoids testing.

Colorado unveils plan to bolster state support of hemp industry

30-Mar-2021 By Hank Schultz

The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...

Caution replaces euphoria as hemp event attendees wrestle with changing market

29-Mar-2021 By Hank Schultz

The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...

CBD safety: Large-scale study finds no evidence of liver toxicity from oral CBD products

23-Mar-2021 By Stephen Daniells

Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.

NPA, others support CA CBD bill while still advocating for federal solution

11-Mar-2021 By Hank Schultz

Yesterday the Natural Products Association testified in favor of a California bill to regulate the CBD trade in that state. NPA and others, however, have reiterated a call for federal legislation that would forestall the growing patchwork quilt of state...

Industry group clarifies hemp definition in wake of Delta-8 THC confusion

10-Mar-2021 By Hank Schultz

Recent news reports about the marketing of products featuring Delta-8 THC as a prominent constituent have muddied the waters enough that the US Hemp Roundtable felt it necessary to clarify again what should—and shouldn’t—be called a hemp product.

NPA urges FDA to stem tide of counterfeit products, move forward on CBD

07-Jan-2021 By Hank Schultz

Federal regulators could do more to protect consumers by using existing import authorities as well as moving forward on hemp/CBD regulation, the National Products Association has said.

GNC meets with White House office to advocate for CBD in supplements

30-Sep-2020 By Hank Schultz

GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.

Lazarus Naturals surfs growing wave of CBG products

31-Aug-2020 By Hank Schultz

Hemp plants contain dozens of bioactive cannabinoid molecules and one of them, CBG, is starting to edge onto the main stage with its better known peer, CBD.

Despite raw material oversupply issues, hemp/CBD market forecast to grow strongly

28-Aug-2020 By Hank Schultz

Robust growth for the hemp/CBD sector was forecast during an online event hosted yesterday by the American Herbal Products Association.

CBD industry headed toward big overcapacity, expert asserts

24-Aug-2020 By Hank Schultz

The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.

GUEST ARTICLE: We need a 90% purity rule for CBD products

24-Aug-2020 By Will Kleidon, founder & CEO, Ojai Energetics

It is time for President Trump to step in and bring clarity to the sale and regulation of CBD products to the public.

Hemp groups dial up pressure for federal CBD regulation

21-Aug-2020 By Hank Schultz

Hemp industry groups have been submitting plans to the federal government for regulation of the space, something they say is urgently needed.

Advocates hopeful bill will pass this month to open California to CBD in supplements and foods

04-Aug-2020 By Hank Schultz

A bill before the California State legislature would open the country’s largest market to dietary supplements and foods containing CBD, but advocates say time is running out while the machinery of state government is preoccupied with pandemic concerns.

New high capacity Colorado CBD extractor enters market

31-Jul-2020 By Hank Schultz

Vantage Hemp, a new hemp/CBD processor, is entering the market with a high capacity facility nearing completion in Colorado.

Amendment to military funding bill would allow soldiers to openly use CBD products

24-Jul-2020 By Hank Schultz

An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...

CBD firms team up with CRO to conduct large scale safety study

10-Jun-2020 By Hank Schultz

A group of hemp/CBD purveyors have teamed up with a clinical research firm to conduct a large scale study to provide the safety data that the US Food and Drug Administration says it lacks.

‘No CBD isolate’ and ‘zero THC’ claims indicative on ongoing regulatory uncertainty

21-May-2020 By Hank Schultz

New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’

Texas proposes rules for consumable hemp products

11-May-2020 By Hank Schultz

The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...

Where next for hemp and CBD? Join us for a FREE webinar to explore growth opportunities in an uncertain environment

20-Apr-2020 By Elaine Watson

It’s a tough time to launch a new CBD food or beverage brand, with COVID-19 upending timetables, trade shows cancelled, and continued regulatory uncertainty as firms wait for clarity from the FDA. However, e-commerce presents growth opportunities, and...

Large Colorado CBD producer announces program to keep hemp farmers in market

16-Apr-2020 By Hank Schultz

Colorado based CBD producer EcoGen Laboratories has announced a program to support hemp farmers during a tumultuous time in the market.

Curaleaf buoyed by increase in hemp oil demand during crisis

30-Mar-2020 By Hank Schultz

Consumers seem to be turning to hemp and cannabis products during the current crisis, which has buoyed the near term outlook for Curaleaf, one of the largest companies in the sector, which posted strong revenue growth in its recent annual report.

CBD pioneer Charlotte’s Web exits startup phase with $95 million in revenue, acquisition

24-Mar-2020 By Hank Schultz

CBD firm Charlotte’s Web reported $94.6 million in revenue in its annual report and announced an acquisition that expands its distribution into topical products.

FDA report on CBD seen as ‘disappointing’ recap of status quo

06-Mar-2020 By Hank Schultz, Elaine Watson and Elizabeth Crawford

A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.

FDA chief Hahn says it would be ‘fool’s game’ to try to shut down CBD markets

28-Feb-2020 By Hank Schultz

FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”

Are all hemp extracts the same? Ojai Energetics talks bioavailability as it teams up with LIFEAID on CBD beverage launch

13-Feb-2020 By Elaine Watson

After an explosive start in late 2019 (it sold 200,000 cans in 36 hours on Black Friday via its website) LIFEAID has secured listings in 350 Vitamin Shoppe stores (in CBD-friendly states), Lucky’s Market in Colorado, and New Seasons for its new CBD-infused...

FDA asks for $5 million for CBD initiatives; industry groups cautiously in favor

12-Feb-2020 By Hank Schultz

A $5 million FDA budget request earmarked for CBD initiatives has garnered the cautious support of dietary supplement stakeholders.

WATCH: Hemp-derived CBD... navigating the regulatory minefield

31-Jan-2020 By Elaine Watson

The FDA has promised to provide more clarity over CBD “in the coming weeks.” But how should brands navigate the regulatory minefield in the meantime, and what options does the agency have?